SCHEMBL27029643

SCHEMBL27029643

CCOc1c(C)cc(-c2ccc3c(c2)CCC(C)(C)[C@H]3NC(=O)O)cc1C

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGAT1 O75907 6/20 0.32
CNR1 P21554 5/20 0.32
CNR2 P34972 5/20 0.32
PPARD Q03181 1/20 0.32
KDM4E B2RXH2 1/20 0.32
ALDH1A1 P00352 1/20 0.32
GLA P06280 1/20 0.32
GAA P10253 1/20 0.32
MAPT P10636 1/20 0.32
HPGD P15428 1/20 0.32
HSD17B10 Q99714 1/20 0.32
HCRTR1 O43613 1/20 0.32
HCRTR2 O43614 1/20 0.32
LIPG Q9Y5X9 1/20 0.32
DHODH Q02127 1/20 0.32
RXRA P19793 1/20 0.31
RXRB P28702 1/20 0.31
CCR2 P41597 1/20 0.31
PPARG P37231 1/20 0.31
PPARA Q07869 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27029670 0.92 RXRA (0.32) DGAT1CNR1CNR2PPARDMAPT
SCHEMBL27200722 0.92 RXRA (0.32) DGAT1CNR1CNR2PPARDMAPT
SCHEMBL23363477 0.92 RXRA (0.32) DGAT1CNR1CNR2PPARDMAPT
SCHEMBL27200789 0.91 PPARD (0.34) CNR1CNR2PPARDDHODHRXRA
SCHEMBL23363094 0.91 PPARD (0.34) CNR1CNR2PPARDDHODHRXRA
SCHEMBL27029681 0.91 PPARD (0.34) CNR1CNR2PPARDDHODHRXRA
SCHEMBL27212710 0.89 CNR1 (0.33) CNR1CNR2KDM4EALDH1A1GLA
SCHEMBL27029752 0.89 CNR1 (0.33) CNR1CNR2KDM4EALDH1A1GLA
SCHEMBL27029660 0.88 CNR1 (0.40) DGAT1CNR1CNR2ALDH1A1DHODH
SCHEMBL27029545 0.87 PPARD (0.42) CNR2PPARDMAPTRXRARXRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4308561-A1 NOVEL COMPOUNDS HAVING INHIBITORY ACTIVITY AGAINST GLUCOSYLCERAMIDE SYNTHASE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PROCESSES FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME Yuhan Corporation (KR) 2024-01-24 EP claimed
EP-4308561-A1 NOVEL COMPOUNDS HAVING INHIBITORY ACTIVITY AGAINST GLUCOSYLCERAMIDE SYNTHASE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PROCESSES FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME Yuhan Corporation (KR) 2024-01-24 EP disclosed